BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 29782220)

  • 1. RNA Therapeutics (Almost) Comes of Age: Targeting, Delivery and Endosomal Escape.
    Dowdy SF; Levy M
    Nucleic Acid Ther; 2018 Jun; 28(3):107-108. PubMed ID: 29782220
    [No Abstract]   [Full Text] [Related]  

  • 2. GalNAc-siRNA Conjugates: Leading the Way for Delivery of RNAi Therapeutics.
    Springer AD; Dowdy SF
    Nucleic Acid Ther; 2018 Jun; 28(3):109-118. PubMed ID: 29792572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extrahepatic Targeting of Oligonucleotides with Receptor-Binding Non-Immunoglobulin Scaffold Proteins.
    Winkler J
    Nucleic Acid Ther; 2018 Jun; 28(3):137-145. PubMed ID: 29733239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current Challenges in Delivery and Cytosolic Translocation of Therapeutic RNAs.
    Johannes L; Lucchino M
    Nucleic Acid Ther; 2018 Jun; 28(3):178-193. PubMed ID: 29883296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intracellular Trafficking and Endosomal Release of Oligonucleotides: What We Know and What We Don't.
    Juliano RL
    Nucleic Acid Ther; 2018 Jun; 28(3):166-177. PubMed ID: 29708838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delivery of RNA Therapeutics: The Great Endosomal Escape!
    Dowdy SF; Setten RL; Cui XS; Jadhav SG
    Nucleic Acid Ther; 2022 Oct; 32(5):361-368. PubMed ID: 35612432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent Advances in Preclinical Research Using PAMAM Dendrimers for Cancer Gene Therapy.
    Tarach P; Janaszewska A
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33805602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nucleic acid delivery for therapeutic applications.
    Gupta A; Andresen JL; Manan RS; Langer R
    Adv Drug Deliv Rev; 2021 Nov; 178():113834. PubMed ID: 34492233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipid Nanoparticles Enabling Gene Therapies: From Concepts to Clinical Utility.
    Kulkarni JA; Cullis PR; van der Meel R
    Nucleic Acid Ther; 2018 Jun; 28(3):146-157. PubMed ID: 29683383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mesoporous Silica Nanoparticles as Carriers for Intracellular Delivery of Nucleic Acids and Subsequent Therapeutic Applications.
    Cha W; Fan R; Miao Y; Zhou Y; Qin C; Shan X; Wan X; Li J
    Molecules; 2017 May; 22(5):. PubMed ID: 28492505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endosomal escape of RNA therapeutics: How do we solve this rate-limiting problem?
    Dowdy SF
    RNA; 2023 Apr; 29(4):396-401. PubMed ID: 36669888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current Status of Messenger RNA Delivery Systems.
    Stanton MG
    Nucleic Acid Ther; 2018 Jun; 28(3):158-165. PubMed ID: 29688817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Systematic Study of Unsaturation in Lipid Nanoparticles Leads to Improved mRNA Transfection In Vivo.
    Lee SM; Cheng Q; Yu X; Liu S; Johnson LT; Siegwart DJ
    Angew Chem Int Ed Engl; 2021 Mar; 60(11):5848-5853. PubMed ID: 33305471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Editorial: Overview on microRNAs in Cancer Development and Virus Infection.
    Poltronieri P
    Microrna; 2016; 5(2):80-82. PubMed ID: 27966400
    [No Abstract]   [Full Text] [Related]  

  • 15. RNAi therapeutics: principles, prospects and challenges.
    Aagaard L; Rossi JJ
    Adv Drug Deliv Rev; 2007 Mar; 59(2-3):75-86. PubMed ID: 17449137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Favorable biodistribution, specific targeting and conditional endosomal escape of RNA nanoparticles in cancer therapy.
    Xu C; Haque F; Jasinski DL; Binzel DW; Shu D; Guo P
    Cancer Lett; 2018 Feb; 414():57-70. PubMed ID: 28987384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A high-throughput Galectin-9 imaging assay for quantifying nanoparticle uptake, endosomal escape and functional RNA delivery.
    Munson MJ; O'Driscoll G; Silva AM; Lázaro-Ibáñez E; Gallud A; Wilson JT; Collén A; Esbjörner EK; Sabirsh A
    Commun Biol; 2021 Feb; 4(1):211. PubMed ID: 33594247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipid-based nanoparticles in the systemic delivery of siRNA.
    Lin Q; Chen J; Zhang Z; Zheng G
    Nanomedicine (Lond); 2014 Jan; 9(1):105-20. PubMed ID: 24354813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aptamer-Mediated Delivery and Cell-Targeting Aptamers: Room for Improvement.
    Yan AC; Levy M
    Nucleic Acid Ther; 2018 Jun; 28(3):194-199. PubMed ID: 29883295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of gene expression by antisense and antigene oligodeoxynucleotides and small interfering RNA.
    Mahato RI; Cheng K; Guntaka RV
    Expert Opin Drug Deliv; 2005 Jan; 2(1):3-28. PubMed ID: 16296732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.